Skip to main content
Article thumbnail
Location of Repository

Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients

By Vera Eickel, Barbara Kahl, Beatrice Reinisch, Angelika Dübbers, Peter Küster, Claudia Brandt and Barbara Spellerberg


Streptococcus agalactiae is a well-known pathogen for neonates and immunocompromized adults. Beyond the neonatal period, S. agalactiae is rarely found in the respiratory tract. During 2002–2008 we noticed S. agalactiae in respiratory secretions of 30/185 (16%) of cystic fibrosis (CF) patients. The median age of these patients was 3–6 years older than the median age CF patients not harboring S. agalactiae. To analyze, if the S. agalactiae isolates from CF patients were clonal, further characterization of the strains was achieved by capsular serotyping, surface protein determination and multilocus sequence typing (MLST). We found a variety of sequence types (ST) among the isolates, which did not substantially differ from the MLST patterns of colonizing strains from Germany. However serotype III, which is often seen in colonizing strains and invasive infections was rare among CF patients. The emergence of S. agalactiae in the respiratory tract of CF patients may represent the adaptation to a novel host environment, supported by the altered surfactant composition in older CF patients

Topics: ddc:610
Year: 2009
OAI identifier:

Suggested articles


  1. (2007). Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness.
  2. (2000). Betahaemolytic streptococci isolated from acute sore-throat patients: cause or coincidence?Acase-controlstudyingeneralpractice.ScandJInfectDis32:377–84.
  3. (1981). Carriage of group B streptococci in the upper respiratory tract.
  4. (2006). Cystic fibrosis since
  5. (1997). Demirsoy A
  6. (2006). Epidemiology of Streptococcus agalactiae colonization in Germany.
  7. (2006). Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.
  8. (2007). Evaluation of the Merlin MICRONAUT system for rapid direct susceptibility testing of gram-positive cocci and gram-negative bacilli from positive blood cultures.
  9. (2001). Group B streptococcal disease in nonpregnant adults.
  10. (1990). High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B).
  11. (1999). Laboratory practices for prenatal Group B streptococcal screening and reporting–Connecticut,
  12. (2002). Lung infections associated with cystic fibrosis.
  13. (1998). Microbiology of sputum from patients at cystic fibrosis centers in the United States.
  14. (2008). Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites.
  15. (2005). Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching.
  16. (2004). Multiplex PCR assay for direct identification of group B streptococcal alpha-protein-like protein genes.
  17. (1992). Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.
  18. (2000). Pathogenesis of neonatal Streptococcus agalactiae infections.
  19. (1977). Pharyngeal carriage of group B streptococci: detection by three methods.
  20. (2005). Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
  21. PrunierAL,MalbrunyB,LauransM,BrouardJ,DuhamelJF,etal.(2003)Highrate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains.
  22. (2004). Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.
  23. (2005). Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany.
  24. (2002). Serotype identification of group B streptococci by PCR and sequencing.
  25. (2003). Six-month multicenter study on invasive infections due to group B streptococci in Argentina.
  26. (2005). Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.
  27. (1997). Surfactant protein A-deficient mice are susceptible to group B streptococcal infection.
  28. (2006). Surfactant protein A–from genes to human lung diseases.
  29. TakahashiS, Oliver KA,ChanMS, et al.(2003) Multilocus sequence typing system for group B streptococcus.
  30. (2001). The relative contributions of recombination and point mutation to the diversification of bacterial clones.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.